Vernalis PLC (VER.L)

Pharmaceuticals - Diversified

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Share Price

Share Intraday Performance
+1.0p (+2.61%)
Bid: 37.3p Offer: 39.3p
As of: 21 Oct 2016 12:06
Market Capitalisation: £201.27 million
Shares In Issue: 526.20 million
PE: 0
Dividend Yield: 0

Share Performance

52 week high:   74.8p on 28-Oct-15
52 week low:   32.8p on 29-Jun-16

Financial History

to Dec '14to Jun '15to Jun '16
Operating Profit-£8m-£12m-£24m
Total Operating Expense£20m£32m£36m
Net Profit-£3m-£6m-£15m
Net Profit Before Taxes-£5m-£9m-£15m
Net Profit After Taxes-£3m-£6m-£15m

Sponsored by:

Company Information
Number of Shares Out 526.20m
Number of Shares Floating 520.48m
Number of Common Share Holders 15,059
Number of Employees 103
Key Figures
Volume (10 day Avg.) 0.15386m
Turnover £12.03m
Profit Before Tax £-14.50m
EPS -3.18p
Cashflow Per Share -2.89p
Cash Per Share 15.97p